Delveinsight Business Research LLP DelveInsight’s “Urea Cycle Disorders Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understand… Read More

Identifying & Addressing “Pain Points” in the Insights Management Process In collaboration with The following authors contributed to thi… Read More

The question on the minds of Medical Affairs: What should I know about generative Artificial Intelligence (AI) and its impact on my organization? Fueled by the rapid growth of ChatGPT… Read More

On August 30, 2023, it was reported that the Swiss National Bank had reduced its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) by 10.5% during the first quarter of the year. This… Read More

The AAV Vectors in Gene Therapy Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of AAV Vectors in Gene Therapy treatments, including those already in the mark… Read More

Read More

No-load mutual funds differ from load-bearing funds in that they do not charge sales commission when investors purchase or sell shares, instead collecting operating expenses as annual fees i… Read More

UKG, a leading provider of HR, payroll, and workforce management solutions for all people, has completed the acquisition of Immedis, a leading global payroll provider with technology and ser… Read More

UKG, a leading provider of HR, payroll, and workforce management solutions for all people, has completed the acquisition of Immedis, a leading global payroll provider with technology an… Read More

Enthesopathy Treatment Market A study by PMR concludes that, “Enthesopathy Treatment Market: Global Opportunities, Challenges, Strategies and Forecasts 2025” has been added on Pe… Read More

A customer used an automated teller machine (ATM) at a Truist Bank branch in Dallas, Texas, US, on Friday, April 14, 2023. Shelby Tauber | Bloomberg | Getty Images The health care s… Read More

Tumour-induced osteomalacia (TIO) is a rare disorder characterized by weakened bones due to the excess secretion of a hormone called fibroblast growth factor 23 (FGF23) by a benign tum… Read More

Tumour-Induced Osteomalacia (TIO) is a rare and debilitating condition that affects the bones, causing them to become weak and brittle. The condition is caused by a benign tumour that secret… Read More

Tumour-Induced Osteomalacia (TIO) is a rare and debilitating condition that affects the bones, causing them to become weak and brittle. The condition is caused by a benign tumour that secre… Read More

DelveInsight’s, “Adeno Associated Virus Vectors in Gene Therapy Pipeline Insight 2023″ report provides comprehensive insights about 70+ companies and 235+ pipeline drugs i… Read More

The phenylketonuria treatment market is expected to register a CAGR of around 11 % over the forecast period. The growing burden of phenylketonuria disease and the novel treatments emerging r… Read More

Ornithine-Transcarbamylase Deficiency is an inherited disorder that causes ammonia in the blood which is identified by complete or partial lack of enzyme ornithine trascarbamylase (OTC). The… Read More

The latest data from GuruFocus shows that CFO & Executive Vice President Mardi Dier sold 3484 shares of Ultragenyx Pharmaceutical Inc (RARE) on 2022-10-12. Investors may be concerned… Read More

According to Bloomberg.com, the fourteen research firms that follow Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have provided the company with a rating of “Moderate Buy” as a r… Read More

Delveinsight Business Research LLP The Hemophilia A therapeutic market is anticipated to grow in the coming years owing to the rise in healthcare spending worldwide and the launch of em… Read More

The COVID-19 pandemic has ushered in an era of rapid innovation in the biotechnology industry. Pharmaceutical and biotech companies alike joined in the race to create an effective and safe C… Read More

Research Nester published a report titled “Phenylketonuria Drugs market– Global Demand Analysis and Opportunity Outlook 2029” which delivers detailed overview of… Read More

Read More

Bayer has made its cell and gene therapy ambition known through two buyouts that fed a new division dedicated to the cutting-edge technologies. Now, the German conglomerate is adding more… Read More

The global skeletal dysplasia market size is expected to reach USD 3.6 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.0% CAGR over the forecast peri… Read More

16 Metabolic Disease Drugs In February, the FDA approved Esperion Therapeutics’ Nexletol and Nexlizet respectively. On the basis of controlling diet and taking the maximum tolerated… Read More

Betting on a single stock can be risky. Returns are never guaranteed. So, small cap ETFs can be one of the best ways to lower risk and generate long-term wealth. Exchange-traded funds (ETFs… Read More

Clker-Free-Vector-Images / Pixabay FDA authorizes Moderna COVID-19 vaccine; McKesson, US Army to help roll out millions of doses to augment national supply. Dispersal of Moderna Inc.’s… Read More

The global skeletal dysplasia market size is expected to reach USD 3.6 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.0% CAGR over the forecast peri… Read More

Global Skeletal Dysplasia Market is set to witness a stable CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Skeletal dysplas… Read More

Life threatening diseases can be treated using novel cell and gene therapy based medicines. These drugs have a different mechanism of action in the body but also very different drug develop… Read More